Delivery Order SPE2D021DA002-SPE2D325F463Y
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $2,093.62 for the supply of Isentress 400 mg tablets (60-count) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a tactical procurement of antiretroviral medication to support Department of Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 11, 2025, for the supply of Isentress 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,093.62. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499.99...
- On August 28, 2025, the Defense Logistics Agency (DLA), operating under the Medical Supply Chain division, awarded a firm fixed-price delivery order valued at $2,093.62 to DMS Pharmaceutical Group Inc. for the supply of Isentress 400 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order with an ultimate completion date of August 29, 2025. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,429.30 for 60 tablets of Isentress 400 mg on June 3, 2025, with an ultimate completion date of June 6, 2025. The contract carries no set-aside designation and is funded through the Medical Supply Chain, a Defense agency component. This delivery order represents a single pharmaceutical transaction under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, to supply Isentress 400 mg tablets (60-count units) to the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, valued at $20,936.20, represents a single-award contract with an ultimate completion date of August 26, 2025. The award was made without a set-aside designation, enabling DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 60 tablets of Isentress 400 mg with a ceiling value of $6,280.86. This firm fixed-price delivery order, which is due for completion by July 31, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,280.86 on August 18, 2025, for the supply of Isentress 400 mg tablets (60-count units). This firm fixed-price delivery order, with an ultimate completion date of August 19, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The award represents a continuation of DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18.8K on August 25, 2025, for the supply of Isentress 400 mg tablets (60-count units). The award was issued by the Defense Logistics Agency's Medical Supply Chain division with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents a single purchase order under DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- This delivery order, valued at $1,429.30, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isentress 400 mg tablets (60-count units). The award was issued on June 6, 2025, under a firm fixed-price contract type with an ultimate completion date of June 11, 2025. The product will be delivered to Park Ridge, Illinois, and the contract was funded by the Defense Logistics Agency's Medical Supply Chain...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F463YDelivery Order
The U.S. Defense Logistics Agency, operating through the Medical Supply Chain division, awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for $2,093.62 on September 29, 2025. The order covers 60 tablets of Isentress 400 mg, an antiretroviral medication used in HIV treatment, with delivery to Park Ridge, Illinois and a completion deadline of September 30, 2025. This delivery order was issued without a set-aside designation, leveraging the vendor's status as a woman-owned small business to compete in federal procurement markets. DMS Pharmaceutical Group Inc., a pharmaceutical wholesaler headquartered in Park Ridge, Illinois, holds a substantial single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026 under the SPE2DB program. This delivery order represents one of many firm fixed-price orders issued under that master contract to supply pharmaceutical products to Department of Defense healthcare facilities. The vendor's federal contract portfolio demonstrates extensive experience distributing branded and generic prescription medications, biologics, and medical consumables to military health systems nationwide, positioning it as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/29/25 |